<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04947007</url>
  </required_header>
  <id_info>
    <org_study_id>2020/1830</org_study_id>
    <nct_id>NCT04947007</nct_id>
  </id_info>
  <brief_title>Comparison of Different Local Anesthetic Dose in Suprascapular and Axillary Blocks in Shoulder Arthroscopies</brief_title>
  <official_title>Comparison of the Efficacy of Different Local Anesthetic Dosage in Suprascapular and Axillary Blocks in Shoulder Arthroscopy Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The research is designed as a single-center, prospective, randomized double-blind study. The&#xD;
      patients undergoing shoulder arthroscopy surgery in Istanbul University, Istanbul Faculty of&#xD;
      Medicine, Department of Orthopedics and Traumatology will be included. Patients who are&#xD;
      legally authorized to make decisions on their behalf will be informed about the research and&#xD;
      their written consent will be obtained. Patients who do not give consent will be excluded.&#xD;
      Ultrasonography (USG) guided combined suprascapular and axillary block will be performed&#xD;
      routinely for postoperative analgesia. After the block is performed, general anesthesia will&#xD;
      be applied. The patients will be divided into 4 groups. Three different doses of local&#xD;
      anesthetic will be given to patients (30 cc vs 20 cc vs 10 cc). Local anesthetic dose will be&#xD;
      the same for suprascapular and axillary blocks. The fourth group will be sham control. Pain&#xD;
      score will be determined by visual pain scoring (VAS) and analgesic consumption will be&#xD;
      provided by the use of a patient controlled analgesia (PCA) device with intravenous morphine&#xD;
      applied in routine practice to all four groups at the postoperative 1, 4, 8,12 and 24 hours.&#xD;
      Patient will be observed for postoperative nausea and vomiting, first time to mobilization,&#xD;
      length of hospital stay, analgesic consumption and satisfaction of surgeon and patient.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators research was designed as a single-center, prospective, randomized&#xD;
      double-blind study.&#xD;
&#xD;
      After the approval of the Ethics Committee, the study will start and is aimed to be completed&#xD;
      in 6 months. The patients consecutively undergoing shoulder arthroscopy surgery in Istanbul&#xD;
      University Istanbul Faculty of Medicine, Department of Orthopedics and Traumatology will be&#xD;
      included. Patients who are legally authorized to make decisions on their behalf will be&#xD;
      informed about the research and their written consent will be obtained. Patients who do not&#xD;
      give consent will not be included in the study.&#xD;
&#xD;
      Preoperative evaluation of the patients will include detailed history, demographic and&#xD;
      clinical parameters including gender, age, indication for shoulder arthroscopy, creatinine,&#xD;
      chronic disease history will be recorded. Patients will be taken to the operating room after&#xD;
      premedication with 2 mg midazolam and 50 mg fentanyl.&#xD;
&#xD;
      Patients will be monitored for rhythm, blood oxygen and pressure in the operating room.&#xD;
      Ultrasonography (USG) guided suprascapular and axillary block will be performed.&#xD;
      Suprascapular and axillary block will be done for postoperative analgesia. After the block is&#xD;
      done, general anesthesia will be applied. In this study there will be four groups with the&#xD;
      control group included. For the first group 15cc+15cc , for the second group 10cc+10cc for&#xD;
      the third group 5cc+5cc of local anesthetic will be injected. The fourth group will be sham&#xD;
      control.&#xD;
&#xD;
      Pain score will be determined by visual pain scoring (VAS) and analgesic consumption will be&#xD;
      provided by the use of a patient controlled analgesia (PCA) device with intravenous morphine&#xD;
      applied in routine practice to all four groups at the postoperative 1, 4, 8,12 and 24 hours.&#xD;
      Patients will be followed up for 48 hours postoperatively in routine practice. They will be&#xD;
      observed for postoperative nausea and vomiting, first mobilisation time, lenght of hospital&#xD;
      stay, analgesic consumption and surgent and patient satisfaction.&#xD;
&#xD;
      Before the study, it was determined that at least 132 patients should be collected in the&#xD;
      power analysis performed with the help of similar literature data. After collecting the&#xD;
      demographic data and morphine consumption data of the patients, statistical analysis will be&#xD;
      performed with Statistical Package for the Social Sciences (SPSS). The investigators study&#xD;
      does not contain any modifications other than the investigators daily routine practices.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2021</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Actual">November 17, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale (0-10) pain scores for patients</measure>
    <time_frame>48 hours</time_frame>
    <description>The VAS (Visual Analog Scale, 0 ''no pain'', to 10, ''the worst pain possible'')</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid (mg) consumption</measure>
    <time_frame>postoperative period up to 48th hours.</time_frame>
    <description>Opioid (mg) consumption</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time of onset of narcotic analgesic need</measure>
    <time_frame>postoperative period up to 48th hours.</time_frame>
    <description>(If VAS &gt; 4, morphine 0.05 mg/kg IV will be administered as rescue analgesia additional analgesia and maximum will be increased to 10 mg.</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of side effects</measure>
    <time_frame>postoperative period up to 48th hour</time_frame>
    <description>Incidence of nausea and vomiting</description>
  </other_outcome>
  <other_outcome>
    <measure>Time until postoperative first mobilization</measure>
    <time_frame>Up to 48 hours</time_frame>
    <description>First mobilization time</description>
  </other_outcome>
  <other_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Through study completion, an average of 1 week</time_frame>
    <description>Hospitalization</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>postoperative period up to 48th hours and postoperative in the first month</time_frame>
    <description>Satisfaction score; 0- very unsatisfied, 3- very satisfied</description>
  </other_outcome>
  <other_outcome>
    <measure>Surgeon satisfaction</measure>
    <time_frame>postoperative period up to 48th hours and postoperative in the first month</time_frame>
    <description>Satisfaction score; 0- very unsatisfied, 3- very satisfied</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group, US guided suprascapulary and axillary nerve block will be performed with 15cc+15c local anesthetic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group, US guided suprascapulary and axillary nerve block will be performed with 10cc+10c local anesthetic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group, US guided suprascapulary and axillary nerve block will be performed with 5cc+5c local anesthetic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group, US guided suprascapulary and axillary nerve block will be performed with serum physiologic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine hydrogen chloride (HCl) 0.025 % in 15+15 ML Injection</intervention_name>
    <description>In this group, US guided suprascapulary and axillary block will be performed with 15 ml +15 ml 0.025% bupivacaine for each block site using a 22 gauge 10 mm block needle.</description>
    <arm_group_label>Group 1</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine HCl 0.025 % in 10+10 ML Injection</intervention_name>
    <description>In this group, US guided suprascapulary and axillary block will be performed with 10 ml +10 ml 0.025% bupivacaine for each block site using a 22 gauge 10 mm block needle.</description>
    <arm_group_label>Group 2</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine HCl 0.025 % in 5+5 ML Injection</intervention_name>
    <description>In this group, US guided suprascapulary and axillary block will be performed with 5 ml +5 ml 0.025% bupivacaine for each block site using a 22 gauge 10 mm block needle.</description>
    <arm_group_label>Group 3</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isotonic solution</intervention_name>
    <description>In this group, US guided suprascapulary and axillary block will be performed with isotonic solution</description>
    <arm_group_label>Group 4</arm_group_label>
    <other_name>serum physiologic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled for total shoulder arthroscopy surgery&#xD;
&#xD;
          -  Patients with American Society of Anesthesiology (ASA) Class 1-3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of regional anesthesia&#xD;
&#xD;
          -  Infection on the local anesthetic application area&#xD;
&#xD;
          -  Patients with known coagulopathy&#xD;
&#xD;
          -  Known allergy against local anesthetics&#xD;
&#xD;
          -  Anatomical difficulties to perform supra scapular and axillary blocks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nil R Kirsan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nur Canbolat, MD</last_name>
    <phone>+905325162583</phone>
    <email>drnurekiz@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mehmet I. Buget, Assoc. Prof.</last_name>
    <phone>+902124142000</phone>
    <phone_ext>31742</phone_ext>
    <email>mbuget@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istanbul University</name>
      <address>
        <city>Istanbul</city>
        <state>Fatih</state>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehmet İlke Büget, Assoc.Prof.</last_name>
      <phone>+902124142000</phone>
      <phone_ext>31742</phone_ext>
      <email>mbuget@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Lee JJ, Kim DY, Hwang JT, Song DK, Lee HN, Jang JS, Lee SS, Hwang SM, Moon SH, Shim JH. Dexmedetomidine combined with suprascapular nerve block and axillary nerve block has a synergistic effect on relieving postoperative pain after arthroscopic rotator cuff repair. Knee Surg Sports Traumatol Arthrosc. 2020 Sep 25. doi: 10.1007/s00167-020-06288-8. [Epub ahead of print]</citation>
    <PMID>32975624</PMID>
  </reference>
  <reference>
    <citation>Özkan D, Cemaloğlu S, Catma FM, Akkaya T. Effects of suprascapular and axillary nerve block on postoperative pain relief sevoflurane consumption and visual clarity in arthroscopic shoulder surgery. Agri. 2020 Jan;32(1):1-7. doi: 10.14744/agri.2019.04875.</citation>
    <PMID>32030694</PMID>
  </reference>
  <reference>
    <citation>Price D. Optimizing the Combined Suprascapular and Axillary Nerve (SSAX) Block. Reg Anesth Pain Med. 2017 Jan/Feb;42(1):122. doi: 10.1097/AAP.0000000000000518.</citation>
    <PMID>27997490</PMID>
  </reference>
  <reference>
    <citation>Marty P, Rontes O, Delbos A. A Comparison of Combined Suprascapular and Axillary Nerve Blocks to Interscalene Block: Interpret With Caution. Reg Anesth Pain Med. 2017 Mar/Apr;42(2):273-274. doi: 10.1097/AAP.0000000000000551.</citation>
    <PMID>28207648</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 24, 2021</study_first_submitted>
  <study_first_submitted_qc>June 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2021</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Nur Canbolat</investigator_full_name>
    <investigator_title>Principal Investigator, M.D.</investigator_title>
  </responsible_party>
  <keyword>suprascapular nerve block</keyword>
  <keyword>axillary nerve block</keyword>
  <keyword>Regional Anesthesia</keyword>
  <keyword>Analgesic consumption</keyword>
  <keyword>Postoperative analgesia</keyword>
  <keyword>Numeric rating scale</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

